Substitution, in part or totally, of the non-selective β-receptor antagonist oxprenolol for methyldopa in 2,770 treated hypertensive patients resulted in a significant reduction in blood pressure levels and a considerable improvement in the quality of the patient's life.
Get full access to this article
View all access options for this article.
References
1.
AhlmarkG., SaltreH., KorsgrenM. (1974). Reduction of sudden death after myocardial infarction. Lancet2, 1563.
2.
BaylissR. I. S., Harvey-SmithE. A. (1962). Methyldopa in the treatment of hypertension. Lancet1, 763.
3.
BeeversD. G., HamiltonM., FarmianM. J., HarpurJ. E. (1973). Antihypertensive treatment and the course of established cerebral vascular disease. Lancet1. 1407.
4.
BulpittC. J., DolleryC. T., (1973). Side effects of hypotensive agents evaluated by a self administered questionnaire. British Medical Journal3, 485.
5.
DorphS., LethA., DegnbolB., FromA. (1970). Visceral changes in severe hypertension and their response to drug treatment. Acta Medica Scandinavica, 187, 411.
6.
IrvineR. O. H., ObrienK. P.NorthJ. D. K. (1962). Alphamethyldopa in the treatment of hypertension. Lancet, 1, 300.
7.
KannelW. B., WolfP. A., VerterJ., McNamaraP. M. (1970). Epidemiologic assessment of the role of blood pressure in stroke. The Framingham Study. Journal of the American Medical Association, 214, 301.
8.
KannelW. B., GordonT., SchwartzM. J. (1971). Systolic versus diastolic blood pressure and risk of coronary heart disease. American Journal of Cardiology, 27, 355.
9.
KannelW. B., CastelliW. P., McNamaraP. M., McKeeA., FeinleibM. (1972). Role of blood pressure in congestive heart failure. New England Journal of Medicine, 287, 781.
10.
LambertD. M. D. (1974). Hypertension and myocardial infarction. British Medical Journal, 3, 685.
11.
MurphyJ. E., StandenS. M., ForrestW. A. (1974). The addition of oxprenolol to hypertensive patients treated with methyldopa—a General Practice study. Journal of International Medical Research2, 1.
12.
PrichardB. N. C., JohnstonA. W., HillI. D., RosenheimM. L. (1968). Bethanidine, guanethidine and methyldopa in the treatment of hyper tension. British Medical Journal, 1, 46.
13.
SmirkH. (1963). Hypotensive action of methyldopa. British Medical Journal, 1, 46.
14.
TaguchiJ., FreisE. D. (1974). Partial reduction of blood pressure and prevention of complications in hypertension. New England Journal of Medicine, 291, 329.
15.
Veterans Administrative Co-operative Study Group on antihypertensive agents (1967). (1970). Journal of the American Medical Association, 202, 1028. 213, 1143.
16.
WilhelmssonC., VedinJ. A., WilhelmsenL., TibbenG., WerkoL. (1974). Reduction of sudden deaths after myocardial infarction by treatment with alprenolol. Lancet, 2, 1157.
